Edition:
United States

AmerisourceBergen Corp (ABC)

ABC on New York Consolidated

81.40USD
22 Nov 2017
Change (% chg)

$1.94 (+2.44%)
Prev Close
$79.46
Open
$79.98
Day's High
$81.99
Day's Low
$79.58
Volume
1,927,033
Avg. Vol
1,896,858
52-wk High
$97.85
52-wk Low
$71.90

Chart for

About

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment... (more)

Overall

Beta: 0.96
Market Cap(Mil.): $17,751.88
Shares Outstanding(Mil.): 218.08
Dividend: 0.38
Yield (%): 1.87

Financials

  Industry Sector
P/E (TTM): -- 21.38 15.47
EPS (TTM): -- -- --
ROI: -- 11.99 11.81
ROE: -- 13.54 15.76

AmerisourceBergen to pay $625 million to settle U.S. government probe

A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe involving pre-filled syringes, the company said in a filing with U.S. securities regulators on Tuesday.

Nov 21 2017

UPDATE 1-AmerisourceBergen to pay $625 mln to settle U.S. government probe

Nov 21 A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe involving pre-filled syringes, the company said in a filing with U.S. securities regulators on Tuesday.

Nov 21 2017

AmerisourceBergen to pay $625 mln to settle U.S. government probe

Nov 21 A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, has agreed to pay $625 million to resolve a U.S. government probe into its pre-filled syringe program, the company said in a filing with U.S. securities regulators on Tuesday.

Nov 21 2017

AmerisourceBergen to buy drug wholesaler H.D. Smith for $815 mln

AmerisourceBergen Corp said on Monday it would buy privately held U.S. drug wholesaler H. D. Smith for $815 million in cash.

Nov 20 2017

AmerisourceBergen to buy drug wholesaler H.D. Smith for $815 mln

Nov 20 AmerisourceBergen Corp said on Monday it would buy privately held U.S. drug wholesaler H. D. Smith for $815 million in cash.

Nov 20 2017

BRIEF-AmerisourceBergen to acquire H. D. Smith

* AmerisourceBergen Corp - ‍plans to fund acquisition through issuance of new long-term debt​

Nov 20 2017

AmerisourceBergen expects tumbling generic drug prices to settle

AmerisourceBergen Corp said it expects stubbornly low generic drug prices, which have plagued drugmakers and wholesalers, to not deteriorate further next year, and brushed off concerns about Amazon's possible entry into the industry.

Nov 02 2017

UPDATE 3-AmerisourceBergen expects tumbling generic drug prices to settle

* Shares initially rise, before reversing course (Adds details on forecast, CEO and analyst comments; updates shares)

Nov 02 2017

BRIEF-AmerisourceBergen, on conf call, says current trends indicate that generic buy side deflation rate has not worsened

* AmerisourceBergen CEO, on conf call, says an aging U.S. patient population continues to "demand" the support of pharmaceutical intervention​

Nov 02 2017

AmerisourceBergen posts loss on $592 mln charge

Nov 2 Drug distributor AmerisourceBergen Corp on Thursday posted a fourth-quarter net loss as it took a $592 million charge related to litigation and employee severance costs.

Nov 02 2017

Competitors

Earnings vs. Estimates